Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,115 | 37 | 71.9% |
| Travel and Lodging | $436.28 | 4 | 28.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $632.43 | 10 | $0 (2020) |
| Medtronic, Inc. | $278.91 | 2 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $100.71 | 5 | $0 (2020) |
| ACELL, INC. | $83.19 | 3 | $0 (2020) |
| Ethicon US, LLC | $67.99 | 3 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $55.15 | 2 | $0 (2023) |
| ConvaTec Inc. | $40.44 | 2 | $0 (2021) |
| Palette Life Sciences, Inc. | $32.15 | 1 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $29.09 | 1 | $0 (2022) |
| Kowa Pharmaceuticals America, Inc. | $26.37 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21.98 | 1 | THD America, Inc. ($21.98) |
| 2023 | $129.97 | 2 | Medtronic, Inc. ($95.58) |
| 2022 | $331.33 | 7 | Medtronic, Inc. ($183.33) |
| 2021 | $71.12 | 3 | ConvaTec Inc. ($25.18) |
| 2020 | $191.10 | 8 | ACELL, INC. ($52.74) |
| 2019 | $78.23 | 4 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($65.05) |
| 2018 | $35.67 | 2 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($20.29) |
| 2017 | $691.60 | 14 | Intuitive Surgical, Inc. ($597.68) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/23/2024 | THD America, Inc. | — | Food and Beverage | In-kind items and services | $21.98 | General |
| 06/05/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $95.58 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 03/24/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $34.39 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/30/2022 | Kowa Pharmaceuticals America, Inc. | Seglentis (Drug) | Food and Beverage | Cash or cash equivalent | $26.37 | General |
| Category: Pain Management | ||||||
| 09/22/2022 | Medtronic, Inc. | EEA (Device) | Food and Beverage | In-kind items and services | $183.33 | General |
| Category: Surgical Stapling | ||||||
| 06/20/2022 | Palette Life Sciences, Inc. | DEFLUX (Device) | Food and Beverage | In-kind items and services | $32.15 | General |
| Category: URINARY | ||||||
| 04/21/2022 | Medspira, LLC | — | Food and Beverage | Cash or cash equivalent | $12.89 | General |
| 03/18/2022 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug), Stivarga | Food and Beverage | In-kind items and services | $29.09 | General |
| Category: Oncology | ||||||
| 03/10/2022 | Trevena, Inc. | OLINVYK (Drug) | Food and Beverage | Cash or cash equivalent | $22.50 | General |
| Category: Pain Management | ||||||
| 01/28/2022 | Ethicon US, LLC | CONTOUR (Device) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Endo-Mechanical | ||||||
| 11/20/2021 | ConvaTec Inc. | Natura (Device) | Food and Beverage | Cash or cash equivalent | $25.18 | General |
| Category: Ostomy Care | ||||||
| 09/10/2021 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/25/2021 | Ethicon US, LLC | Echelon Flex (Device), Echelon Circular | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: Endo-Mechanical | ||||||
| 12/24/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2020 | Allergan, Inc. | STRATTICE (Device) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: TRAUMA EMERGENCY, INJURY, SURGERY | ||||||
| 11/09/2020 | ACELL, INC. | — | Food and Beverage | Cash or cash equivalent | $21.61 | General |
| 10/30/2020 | ACELL, INC. | — | Food and Beverage | Cash or cash equivalent | $31.13 | General |
| 02/14/2020 | Vioptix Inc | — | Food and Beverage | Cash or cash equivalent | $25.04 | General |
| Category: T. Ox Tissue Oximeter | ||||||
| 01/24/2020 | Ethicon US, LLC | ECHELON FLEX Stapler (Device), SURGICEL Family of Absorbable Hemostats | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Endo-Mechanical | ||||||
| 01/15/2020 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $34.75 | General |
| Category: SURGERY | ||||||
| 01/10/2020 | PRESCIENT SURGICAL | CleanCision (Device) | Food and Beverage | Cash or cash equivalent | $23.90 | General |
| Category: Wound Retraction and Protection System | ||||||
| 12/09/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/06/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/17/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/23/2019 | DAVOL INC. | PHASIX (Device) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: DAVOL | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 502 | 639 | $152,265 | $73,081 |
| 2022 | 8 | 597 | 766 | $188,815 | $92,793 |
| 2021 | 7 | 632 | 812 | $201,800 | $101,151 |
| 2020 | 7 | 441 | 558 | $136,530 | $61,859 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 46500 | Injection of hemorrhoid | Office | 2023 | 50 | 73 | $36,500 | $21,167 | 58.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 131 | 224 | $38,080 | $16,655 | 43.7% |
| 46600 | Diagnostic exam of anus using an endoscope | Office | 2023 | 94 | 111 | $22,200 | $11,871 | 53.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 105 | 105 | $25,725 | $9,218 | 35.8% |
| 45300 | Diagnostic exam of rectum and lower large bowel using an endoscope | Office | 2023 | 74 | 78 | $15,600 | $7,964 | 51.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $14,160 | $6,205 | 43.8% |
| 46500 | Injection of hemorrhoid | Office | 2022 | 73 | 108 | $54,000 | $31,925 | 59.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 124 | 232 | $39,440 | $17,270 | 43.8% |
| 46600 | Diagnostic exam of anus using an endoscope | Office | 2022 | 110 | 128 | $25,600 | $14,435 | 56.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 122 | 122 | $29,890 | $10,985 | 36.8% |
| 45300 | Diagnostic exam of rectum and lower large bowel using an endoscope | Office | 2022 | 77 | 85 | $17,000 | $8,323 | 49.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 54 | 54 | $15,930 | $7,659 | 48.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 12 | $3,000 | $1,370 | 45.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 11 | $1,155 | $534.46 | 46.3% |
| 45300 | Diagnostic exam of rectum and lower large bowel using an endoscope | Facility | 2022 | 14 | 14 | $2,800 | $291.90 | 10.4% |
| 46500 | Injection of hemorrhoids | Office | 2021 | 75 | 125 | $62,500 | $37,721 | 60.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 127 | 223 | $37,910 | $17,000 | 44.8% |
| 45300 | Diagnostic examination of rectum and lower large bowel using a rigid endoscope | Office | 2021 | 119 | 133 | $26,600 | $13,720 | 51.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 136 | 136 | $33,320 | $12,577 | 37.7% |
| 46600 | Diagnostic examination of the anus using an endoscope | Office | 2021 | 89 | 104 | $20,800 | $11,557 | 55.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 53 | 53 | $15,635 | $6,936 | 44.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 22 | 27 | $2,835 | $1,384 | 48.8% |
| 45300 | Diagnostic examination of rectum and lower large bowel using a rigid endoscope | Facility | 2021 | 11 | 11 | $2,200 | $255.72 | 11.6% |
| 46500 | Injection of hemorrhoids | Office | 2020 | 54 | 82 | $38,600 | $22,432 | 58.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 110 | 178 | $30,260 | $11,349 | 37.5% |
About Dr. Daniel Gingold, MD
Dr. Daniel Gingold, MD is a Surgery healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2011. The National Provider Identifier (NPI) number assigned to this provider is 1376834309.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Gingold, MD has received a total of $1,551 in payments from pharmaceutical and medical device companies, with $21.98 received in 2024. These payments were reported across 41 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,115).
As a Medicare-enrolled provider, Gingold has provided services to 2,172 Medicare beneficiaries, totaling 2,775 services with total Medicare billing of $328,883. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Surgery
- Other Specialties Colon & Rectal Surgery
- Location New York, NY
- Active Since 04/25/2011
- Last Updated 05/16/2017
- Taxonomy Code 208600000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1376834309
Products in Payments
- Da Vinci Surgical System (Device) $632.43
- EEA (Device) $183.33
- INTERSTIM (Device) $95.58
- XIFAXAN (Drug) $85.34
- GATTEX (Drug) $55.15
- DEFLUX (Device) $32.15
- Vitrakvi (Drug) $29.09
- Seglentis (Drug) $26.37
- Echelon Flex (Device) $25.18
- Natura (Device) $25.18
- CONTOUR (Device) $25.00
- CleanCision (Device) $23.90
- OLINVYK (Drug) $22.50
- STRATTICE (Device) $21.49
- ECHELON FLEX Stapler (Device) $17.81
- BRIDION (Drug) $17.71
- EXPAREL (Drug) $16.53
- SUPREP (Drug) $15.38
- TRULANCE (Drug) $15.37
- ESTEEM (Device) $15.26
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgery Doctors in New York
Yuri Novitsky, Md, MD
Surgery — Payments: $918,174
Flavio Malcher Martins De Oliveira, Md, Msc, MD, MSC
Surgery — Payments: $729,836
Michael Marin, Md, MD
Surgery — Payments: $442,103
Rache Simmons, M.d, M.D
Surgery — Payments: $405,951
Tanuja Damani, M.d, M.D
Surgery — Payments: $391,523
Dr. Rasa Zarnegar, Md, MD
Surgery — Payments: $319,664